B
Beat Müllhaupt
Researcher at University of Zurich
Publications - 289
Citations - 17086
Beat Müllhaupt is an academic researcher from University of Zurich. The author has contributed to research in topics: Hepatitis C & Liver transplantation. The author has an hindex of 55, co-authored 258 publications receiving 14656 citations.
Papers
More filters
Journal ArticleDOI
Pathology of Echinococcosis: A Morphologic and Immunohistochemical Study on 138 Specimens With Focus on the Differential Diagnosis Between Cystic and Alveolar Echinococcosis.
Michael Reinehr,Charlotte Micheloud,Felix Grimm,Philipp A Kronenberg,Johannes Grimm,Annika Beck,Juliane Nell,Cordula Meyer Zu Schwabedissen,Eva Furrer,Beat Müllhaupt,Thomas F. E. Barth,Peter Deplazes,Achim Weber +12 more
TL;DR: This work systematically and quantitatively recorded the pathologic spectrum in a clinically and molecularly defined echinococcosis cohort, and defined morphologic criteria, which robustly discriminate between CE and AE.
Journal ArticleDOI
A systematic review and meta-analysis of HCV clearance.
Emeline Gauthiez,Ines Habfast-Robertson,Sina Rüeger,Zoltán Kutalik,Vincent Aubert,Thomas Berg,Andreas Cerny,Meri Gorgievski,Jacob George,Markus H. Heim,Raffaele Malinverni,Darius Moradpour,Beat Müllhaupt,Francesco Negro,David Semela,Nasser Semmo,Jean Villard,Stéphanie Bibert,Pierre-Yves Bochud +18 more
TL;DR: Associations of single nucleotide polymorphisms from nine genes (EIF2AK2, IFNAR2, ITPA, MBL2, MX1, OASL, SPP1, TGFB1, TNK2) with response to interferon‐based therapy are observed and may contribute to a better understanding of hepatitis C virus immunopathogenesis.
Journal ArticleDOI
Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation
Dela Golshayan,Agnieszka Wójtowicz,Stéphanie Bibert,Nitisha Pyndiah,Oriol Manuel,Isabelle Binet,Leo H. Buhler,Uyen Huynh-Do,Thomas F. Mueller,Jürg Steiger,Manuel Pascual,Pascal Meylan,Pierre-Yves Bochud,Rita Achermann,John-David Aubert,Philippe Baumann,Guido Beldi,Christian Benden,Christoph Berger,Elsa Boely,Heiner C. Bucher,Leo Buhler,Thierry Carell,Emmanuelle Catana,Yves Chalandon,Sabina De Geest,Olivier de Rougemont,Michael Dickenmann,Michel A. Duchosal,Thomas Fehr,Sylvie Ferrari-Lacraz,Christian Garzoni,Yvan Gasche,Paola Gasche Soccal,Emiliano Giostra,Daniel Good,Karine Hadaya,Christoph Hess,Sven Hillinger,Hans H. Hirsch,Günther F.L. Hofbauer,Franz Immer,Richard Klaghofer,Michael T. Koller,Thomas Kuntzen,Bettina Laesser,Roger Lehmann,Christian Lovis,Hans-Peter Marti,Pierre-Yves Martin,Paul Mohacsi,Isabelle Morard,Philippe Morel,Ulrike Mueller,Nicolas J. Mueller,Helen Mueller-McKenna,Thomas Müller,Beat Müllhaupt,David Nadal,Gayathri Nair,Jakob Passweg,Chantal Piot Ziegler,Juliane Rick,Eddy Roosnek,Anne Rosselet,Silvia Rothlin,Frank Ruschitzka,Urs Schanz,Stefan Schaub,Christian Seiler,Nasser Semmo,Susanne Stampf,Christian Toso,Dimitri Tsinalis,Christian van Delden,Jean-Pierre Venetz,Jean Villard,Madeleine Wick,Markus J. Wilhelm,Patrick Yerly +79 more
TL;DR: It is suggested that MBL2 polymorphisms result in low MBL serum levels and are associated with acute cellular rejection after kidney transplantation, which may lead to individual risk stratification and customized immunosuppression.
Journal ArticleDOI
Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study.
Andreas Geier,Mareile Eichinger,Guido Stirnimann,David Semela,Fabian Tay,Burkhardt Seifert,Oliver Tschopp,Heike Bantel,Daniel Jahn,Ewerton Marques Maggio,Lanja Saleh,Heike A. Bischoff-Ferrari,Beat Müllhaupt,Jean-François Dufour +13 more
TL;DR: Treatment with 2100 IE vitamin D q.d. over 48 weeks was well tolerated and led to a significant improvement of serum ALT levels in patients with hypovitaminosis D and histology-proven NASH as the primary endpoint together with a trend toward reduction of hepatic steatosis.
Journal ArticleDOI
Relationship between APC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis.
Irene Guldenschuh,Rainer Hurlimann,Andreas Müller,Rudolf W. Ammann,Beat Müllhaupt,Zuzana Dobbie,Gian-Franco Zala,Renata Flury,Walter K. F. Seelentag,Jürgen Roth,Christa Meyenberger,Michael Fried,Thomas Hoppeler,Allan D. Spigelman,Rodney J. Scott,Rodney J. Scott +15 more
TL;DR: It is indicated that sulindac reduces the number of adenomas in the entire colon and that the effect seems to be more pronounced in the proximal colon.